141 related articles for article (PubMed ID: 10798765)
1. The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322.
Nizet Y; Chentoufi AA; de la Parra B; Lewalle P; Rouas R; Cornet A; Besse T; Mourad M; Malaise J; Squifflet JP; Bazin H; Latinne D
Transplantation; 2000 Apr; 69(7):1420-8. PubMed ID: 10798765
[TBL] [Abstract][Full Text] [Related]
2. An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro.
Latinne D; De La Parra B; Nizet Y; Cornet A; Giovino-Barry V; Monroy RL; White-Scharf ME; Bazin H
Int Immunol; 1996 Jul; 8(7):1113-9. PubMed ID: 8757956
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of human naive NK cells mediated by a rat IgG2b anti CD2 mAb through a fractricidal ADCC reaction.
Nizet Y; Chentoufi AA; Havaux X; Kinet I; Cormont F; Bazin H; Latinne D
Immunol Lett; 1999 Jun; 68(2-3):229-35. PubMed ID: 10424425
[TBL] [Abstract][Full Text] [Related]
4. Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibody.
Dehoux JP; Talpe S; Dewolf N; Otsuka M; Oike F; Jamar F; de la Parra B; Latinne D; Bazin H; Gianello P
Transplantation; 2000 Jun; 69(12):2622-33. PubMed ID: 10910286
[TBL] [Abstract][Full Text] [Related]
5. A role for CD2 antibodies (BTI-322 and its humanized form) in the in vivo elimination of human T lymphocytes infiltrating an allogeneic human skin graft in SCID mice: an Fcgamma receptor-related mechanism involving co-injected human NK cells.
Snanoudj R; Rouleau M; Bidère N; Carmona S; Baron C; Latinne D; Bazin H; Charpentier B; Senik A
Transplantation; 2004 Jul; 78(1):50-8. PubMed ID: 15257038
[TBL] [Abstract][Full Text] [Related]
6. Effect in vitro and in vivo of a rat anti-CD2 monoclonal antibody (LO-CD2b) on pig-to-baboon xenogeneic cellular (T and natural killer cells) immune response.
Dehoux JP; de la Parra B; Latinne D; Bazin H; Gianello P
Xenotransplantation; 2001 Aug; 8(3):193-201. PubMed ID: 11472627
[TBL] [Abstract][Full Text] [Related]
7. Selective deletion of antigen-specific, activated T cells by a humanized MAB to CD2 (MEDI-507) is mediated by NK cells.
Branco L; Barren P; Mao SY; Pfarr D; Kaplan R; Postema C; Langermann S; Koenig S; Johnson S
Transplantation; 1999 Nov; 68(10):1588-96. PubMed ID: 10589960
[TBL] [Abstract][Full Text] [Related]
8. The anti-CD2 monoclonal antibody BTI-322 generates unresponsiveness by activation-associated T cell depletion.
Xu Y; Kolber-Simonds D; Hope JA; Bazin H; Latinne D; Monroy R; White-Scharf ME; Schuurman HJ
Clin Exp Immunol; 2004 Dec; 138(3):476-83. PubMed ID: 15544625
[TBL] [Abstract][Full Text] [Related]
9. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
10. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
11. Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells.
Dumont C; Déas O; Mollereau B; Hebib C; Giovino-Barry V; Bernard A; Hirsch F; Charpentier B; Senik A
J Immunol; 1998 Apr; 160(8):3797-804. PubMed ID: 9558083
[TBL] [Abstract][Full Text] [Related]
12. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
13. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
14. Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.
Binder C; Sellberg F; Cvetkovski F; Berg S; Berglund E; Berglund D
Front Immunol; 2021; 12():599526. PubMed ID: 33643309
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
[TBL] [Abstract][Full Text] [Related]
16. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production.
Sido B; Dengler TJ; Otto G; Zimmermann R; Müller P; Meuer SC
Eur J Immunol; 1998 Apr; 28(4):1347-57. PubMed ID: 9565375
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
[TBL] [Abstract][Full Text] [Related]
18. CD2 and CD3 receptor-mediated tolerance: constraints on T cell activation.
Punch JD; Lin J; Bluestone J; Bromberg JS
Transplantation; 1999 Mar; 67(5):741-8. PubMed ID: 10096532
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic study of a clinically effective anti-CD2 monoclonal antibody.
Sellberg F; Berglund D; Binder C; Hope J; Fontenot J; Griesemer A; Sykes M; Sachs DH; Berglund E
Scand J Immunol; 2020 Jan; 91(1):e12839. PubMed ID: 31630416
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against human T cell adhesion molecules--modulation of immune function in nonhuman primates.
Berlin PJ; Bacher JD; Sharrow SO; Gonzalez C; Gress RE
Transplantation; 1992 Apr; 53(4):840-9. PubMed ID: 1348883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]